Analysis of Choices Faced by Mothers of Small Children

How to Land an Interview When You Arent Qualified

How to Land an Interview When You Arent Qualified Anyone searching for a job has spotted classified job ads for what appear to be interesting positions. However, the person’s skills might be less than perfect, and he or she is hesitant to put in an application. Even if your qualifications aren’t a perfect match, should you go ahead and apply? Learn how to prove you are a good match for the position, even if your qualifications aren’t the best match. Not All People Being Interviewed Have the QualificationsThe first thing you need to know when thinking about applying for a position you found in the job classifieds you don’t have all the qualifications for is that you aren’t alone. According to a survey, 92 percent of job seekers find interviews stressful, and 11 percent feel they may be underqualified for the position they are seeking. If you have most of the qualifications the company is looking for, you shouldn’t dismiss applying for the job, especially if you can add on to your skillset to match the qualifications or have other things to offer.Focus on Your SkillsIf a company is advertising for a hire who has extensive experience in a position, this may not be the job to apply for if you are a recent graduate or your experience is limited. However, a lack of technical skills in the job requirements is doable because you can catch up on those before the interview. When your skills are a little short of the mark, focus on your transferrable skills and accentuate your soft skills such as your versatility, how you were an asset in previous jobs and ability to be a team player.Honesty HelpsLet’s say the position calls for five-years of experience in the field, but you only have two. Sometimes, job ads can stretch the qualifications hoping to get that master candidate to apply. That doesn’t mean the company has all the job requirements written in stone. Use this opportunity to explain why you would be a good candidate, despite the shorter work experience.Let Y our Resume Speak for YouA good resume will help get your foot in the door. Write it and include your qualifications that fit the description for the position, ensure that no errors in spelling or grammar exist and follow up a few days later. Being professional and showing interest can’t hurt your chances of getting that important first interview. Use your resume to show what a great candidate you are and how you have the motivation to fit well into the position.Preparation Is Key to a Successful InterviewIt’s easier to conduct a successful interview if you have done your homework and learned about the company. This makes it simpler to answer and ask questions and shows that you are interested in that particular job. You can learn a lot by checking out the company’s website, LinkedIn page and Facebook. Knowledge is power, and appearing knowledgeable about the company shows that you’ve invested some time into learning how you can fit in.Interviews Are Condu cted the Same WayWhether in person or on the phone, interviews are conducted the same way and should be prepared for the same. On a phone interview, dress professionally as you would for an in-person interview and remove any distractions behind you that might interfere, such as a busy background or noise that might disrupt. Prepare in advance since you might not know when the interviewer will call.Confidence, poise and advance preparation can help you get your dream job, even if your qualifications might fall a bit short. TheJobNetwork helps you find job openings the easy way by sending you email notices as soon as those jobs become available. All you need to do is fill out your qualifications and job interests to get started. You can start right now when you sign up with TheJobNetwork.

MULTICULTURAL BUSSINESS MANAGEMENT & Global leadership Essay

MULTICULTURAL BUSSINESS MANAGEMENT & Global leadership - Essay Example ome decided to outource jut certain part of their organization. The telecommunication indutry wa advancing, but Global Communication wa being left behind. I have created thi analyi to how the problem and potential olution Global Communication ha dealt with along with the ethical dilemma faced by the takeholder and the end tate viion of the company. My paper will include the comprehenive gap analyi for Global Communication; what i going with them at thi point in time and where the company i trying to be, regaining the reputation of being one of the larget, progreing global tool throughout the telecommunication indutry. Global Communication uffer from the tre of the indutrie and trying to maintain competition while oberving their tock price falling. The tockholder are preuring Global Communication to correct the problem, along with coming up with new innovative way to keep the conumer wanting to do buine with Global Communication. Thi analyi i deigned to how optional olution to Global Communication preent tribulation, rik management for the uggete d alternative olution, the optimal olution and finally the implementation plan to deal with the problem. ituation Analyi Iue and Opportunity Identification everal iue are acknowledged for Global Communication throughout the ituation. ... Competition i one of the reaon why Global Communication tock ha falling o dratically. Another iue Global Communication faced i the uproar of the employee and union worker becaue of the layoff that are planned. Global Communication leaderhip team came up with thi ingeniou plan to of moving ome of the technical call center to India and Ireland which hould reduce unit cot for handling call by nearly 40%. Although the move will ave Global Communication money, they did not think about the ending cot in human capital. In addition to the other iue provided, Global Communication i having communication problem within. Global Communication i an organization that i conidered one of the bet for taking care of the employee need to make ure they at leat addre all the iue. "By improving deciion making, knowledge management, employee need and coordination; company can progre and retain the name in the communication indutry. Workplace communication ha a ignificant effect on organizational performance (Mchane & Glinow, 205). "Firt organization depend on the ability of people to coordinate their individual work effort toward a common goal (Mchane & Glinow, 25). Global Communication i faced with economic iue in which the leaderhip team i trying to apply trategic planning to retructure the company and make it properou again. Although they have trategically planned a olution, the leaderhip team i having difficultie conveying the new plan to the employee. Local, long ditance and international market are all competing for the ame buine. New calling feature and uite of local and long ditance ervice helped, but the indutry uffered a huge blow at the hand of the cable companie, who tepped in to provide complete olution

A Christmas Carol by Charles Dikens Essay Example | Topics and Well Written Essays - 500 words

A Christmas Carol by Charles Dikens - Essay Example The Past Ghost talked about Scrooge’s boyhood, love life as well as important events in his life which shaped his current negativist personality. For instance, it was told the Scrooge was lonely in his childhood with a dysfunctional family. He was abandoned to study at a boarding school where he eventually developed his antisocial tendencies. Here, we are given a reason why Scrooge could not offer any empathy because in his early developmental years, he had none. He was left to himself, with no affectionate encounters with his parents or his siblings. We highlight the young Ebenezer’s experiences of past Christmases because, it turned out, most unfortunate events happened during this time explaining for Scrooge almost neurotic hatred for the holiday. The story went to describe how Scrooge became obsessed with work and money that eventually drove Belle, his fiancà ©e to leave him. Apparently, business is the only avenue where Scrooge could excel and, perhaps, in his opinion, be appreciated, that is why he became a workaholic. The visit from the three ghosts has given Scrooge a new perspective. Presently, he was his old self – greedy, selfish, bitter and miserly with a particular disgust against Christmas. The ghosts have also shown how his nephew and his poor family, who merely lives on his pittance, were currently happy despite the fact that there was a lame son. When his future was shown to him along with the suggestion that he is being given an opportunity to change, Scrooge finally came around. There was the realization that upon his death, many people will celebrate due to the consequences of his actions. The past experiences seemed to be the major reason why Scrooge could not find it on his own to see how his character has degenerated almost beyond redemption. One of the distinct characteristics that mark Scrooge is his tendency to stifle his past. There seems to be a lot of pain in it for him, not only in what he

Writing Assignment #2 Essay Example | Topics and Well Written Essays - 500 words - 4

Writing Assignment #2 - Essay Example Products in oligopolistic market structures will usually have very few or no substitutes as in the case of oil. The automobile industry in the world also evidences oligopolistic tendencies with a few large car manufactures selling similar auto models across the world. In most cases, players in such industries are torn between competing separately to win the market and coming together to create a monopolistic situation. Normally, the latter case never works as most companies rebrand constantly to differentiate themselves from their competitors. This is clearly seen in the automobile industry where different auto makers are customizing their brands to suite specific categories of people in the market. In a duopoly market structure, where the market players are limited to two, the common situation is normally cooperation between them so as to limit output to the monopoly style (Perloff 78). In such a case, profit is maximized as the price becomes much greater than the marginal cost. A case in point lies in the operation of Coca-Cola and Pepsi cola which operate in a duopoly situation. Most duopolies are created out of collusion between two or more players who agree to jointly set the price and manage output. Production in that is usually more than in a monopolist but less than in the in the completive market. In the same vein, some duopolies operate as cartels where strict cooperation is the order of the day. Price determination in oligopolistic market environments is always the prerogative of the market players. This arises since these players are normally big enough to influence prices in the market unlike in competitive market environments. In any case, prices in such markets are not determined by the interaction of supply and demand but are a function of the cooperation between the competing firms. Such a pricing strategy is known to create myriad inefficiencies in the market as usually evidenced in the oil industry where the need to rake in more profits

Medical Device Regulations in the European Union

Medical Device Regulations in the European Union INTRODUCTION TO MEDICAL DEVICE REGULATIONS IN THE EUROPEAN UNION: A Medical Device under the jurisdiction of the European Union is defined as â€Å"an instrument, apparatus, appliance, material or other article, whether used alone or in combination, together with any software necessary for its proper application, which a) is intended by the manufacturer to be used for human beings for the purpose of i. diagnosis, prevention, monitoring, treatment or alleviation of disease, ii. diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap, iii. investigation, replacement or modification of the anatomy or of a physiological process, or iv. control of conception; and b) does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means†.1 The clinical investigation and the subsequent introduction of a medical device in the European market is primarily regulated and governed by the MHRA (Medicines and Healthcare products Regulatory Agency) with the assistance of competent regulatory institutions called the Notified Bodies. â€Å"A Notified Body is a certification organization which the national authority (the Competent Authority) of a Member State designates to carry out one or more of the conformity assessment procedures described in the annexes of the Directives.†3 The MHRA regulates with the help of two sets of medical device regulations viz. the Statutory Instruments 2002 No.618 (Consolidated legislation) and 2003 No.1697. These legislations employ the three device directives issued by the competent authority into the european law. The directives help the manufacture in better understanding of the manufacturing and the requirments for inroduction into the market of the devices. These directives are: Directive 90/385/EEC: Active Implantable Medical Devices directive Directive 93/42/EEC: Medical Devices directive Directive 98/79/EC: In vitro Diagnostic Medical Device directive Directive 90/385/EEC: Active Implantable Medical Devices directive: This directive encompasses medical devices that are active(i.e powered) and implanted(i.e left in the human body). These include pacemakers, implantable defibrillators, implantable infusion pumps, cochlear implants and implantable neuromuscular stimulators etc. Regulations realizing the Directive came entirely into force in the United Kingdom on January 01 1995. Directive 93/42/EEC: Medical Devices directive: This directive covers an extensive array of devices from uncomplicated bandages to orthopaedic implants and high-end radiology apparatus. Regulations realizing the Directive came entirely into force in the United Kingdom on June 13 1998. Directive 98/79/EC: In vitro Diagnostic Medical Device directive: â€Å"This Directive covers any medical device, reagent, reagent product, kit, instrument, apparatus or system which is intended to be used for the invitro examination of substances derived from the human body, such as blood grouping reagents, pregnancy testing and Hepatitis B test kits. Regulations implementing the Directive came into force in the UK on 7th June 2000 with a transitional period until 7th December 2003. There is no clinical investigation system for in-vitro diagnostic medical devices. Performance evaluations of in vitro diagnostic devices that are performed outside the manufacturers premises should be notified to the UK Competent Authority in accordance with the Medical Devices Regulations 2002: Section 44.†2 The rationale backing these directives is to permit easy movement of the medical devices throughout the European Union whilst upholding high standards of device safety and up-to-the-mark quality. Classification of medical devices: Devices are classified purely based on risk associated with their use. Ranging from low risk to high risk, they are Class I, IIa, IIb and III. A classic example of a class III medical device is a cochlear implant, which is both active and implantable and thus comes under the purview of Directive 90/385/EEC: Active Implantable Medical Devices directive. Let us discuss in detail the regulatory requirments specified as per the MHRA to bring an active implantable cochlear implant into the market designated bt the European Union as the EFTA(European Free Trade Area). â€Å"Examples of AIMDs include: implantable cardiac pacemakers implantable defibrillators leads, electrodes, adaptors for 1) and 2) implantable nerve stimulators bladder stimulators sphincter stimulators diaphragm stimulators cochlear implants implantable active drug administration device catheters, sensors for 9) implantable active monitoring devices programmers, software, transmitters.†4 Cochlear Implants: â€Å"Cochlear implants are electronic hearing prostheses that bypass the damaged hearing components by providing electrical stimulation directly to the auditory nerve fibres in the cochlea. The electrical stimulation is interpreted by the brain as sound. Cochlear implants consist of an external microphone, speech processor and transmitter coil, and an internal stimulator (implanted under the skin just behind the ear) attached to a stimulation electrode which passes into the cochlea. A variation of the cochlear implant is the auditory brainstem implant where electrodes are implanted directly into the auditory area of the brainstem. This can be used in patients who do not have a functional auditory nerve.†5 The regulatory process of bringing a cochlear implant in the European market: It is mandated by law that the manufacturer who intends to bring the device into the EFTA abides by the Essential Requirments stated in the Directive 90/385/EEC: Active Implantable Medical Devices directive and demonstrate the compliance of the device with the safety and efficacy standards set forth in the directive. There are essentially two ways to do it viz. â€Å"either a compilation of the relevant scientific literature currently available on the intended purpose of the device and the techniques employed, together with, if appropriate, a written report containing a critical evaluation of the compilation; or the results and conclusions of a specifically designed clinical investigation†2 Product launch on the basis of evaluation and review of scientific literature can be considered as acceptable if equivalence can be scientifically demonstrated with a device existant in the market and routinely used in clinical practice. Equivalence has to be demonstrated w.r.t technology, critical performance, design, principles of operation, biological safety, population involved, conditions of use and clinical purpose. However, unless satisfactory evidence can be collected by means of scientific literature review, the use of a well-planned clinical trial/investigation should be considered as the best way to attest permissible levels of safety and efficacy. In case of scientific review or pre-clinical assessment, the following fees apply: Class I, IIa, or IIb other than implantable or long-term invasive:  £3,000 (Re-notification incase of objection by MHRA  £2,100). Class IIb implantable or long-term invasive, Class III, and active implantable:  £4,100 (Re-notification incase of objection by MHRA  £2,700). Applications for a proposed clinical investigation of the medical device should be made by filling the forms PCA1 and PCA2 along with the necessary information required by the clauses in the forms. Applications should be labeled clearly as â€Å"documentation only†. The use of English language is mandatory. Documentation should be clear and legible and remain so after reproduction. Electronic applications should be discussed with the MHRA. The manufacturer, for scrutiny by the MHRA should make a total of eight full submission copies available. The charges for the scrutiny of applications are laid out in the Medical Devices Regulations 2002: section 56. They are as follows: â€Å"Fees for Group A (low risk) devices are  £2,700 (initial application) or  £1,800 (resubmission). Increasing to  £3,000 and  £2,100 on 1st April 2008. Fees for Group B (high-risk) devices are  £3,800 (initial application) or  £2,400 (resubmission). Increasing to  £4,100 and  £2,700 on 1 st April 2008.†2 Applications should be forwarded to: Mrs Daniella Smolenska, Medicines Healthcare products Regulatory Agency (MHRA), European and Regulatory Affairs, Market Towers, 1 Nine Elms Lane, London, SW8 5NQ, Tel: 020 7084 3363, Email [emailprotected]. Approval from the MREC (Multi-centre Research Ethics Committee)/LREC (Local Research Ethics Committee) can be obtained along with the notification to the Competent Authority. However, a clinical investigation can begin only after approval has been obtained from the MREC/LREC and the Competent Authority has not raised an objection to the investigation within the 60 days time constraint period; or approval has been obtained from both the authoritative bodies. General Requirements: A well-defined clinical plan whose methodology and ethical considerations conforms to the standards set forth in the Medical Devices Regulations 2002: section 16 and section 29, the Active Implantable Medical Devices Directive, Annexes 6 and 7, and the Medical Devices Directive, Annexes VIII and X. Supplementary standards are set forth in Standard BS EN ISO 14155-1; 2002, â€Å"Clinical Investigation of Medical Devices for Human Subjects-part 1: General Requirements†, and BS EN ISO 14155-2:2002, â€Å"Clinical Investigation of Medical Devices for Human Subjects-part 2: Clinical Plan†. The CA should be notified incase of differences in the EU and non-EU protocols and the reasons for the same. â€Å"All applications must contain a statement (Active Implantable Medical Devices Directive: Annex 6,2.2; Medical Devices Directive: Annex VIII, 2.2): that the device in question conforms to the Essential Requirements except with regard to those aspects of the device that are to be investigated and that in respect of those aspects, every precaution has been taken to protect the health and safety of the patient. By signing this statement, the manufacturer is declaring that the device meets all of the relevant Essential Requirements, other than those subject to the investigation. Manufacturers must therefore ensure that at the time a notification is made to the Competent Authority, they have all documentation required to demonstrate conformity with the relevant Essential Requirements available for submission to the Competent Authority when requested.†2 Device information like name, model, materials used and sterilization standards etc must be provided as set forth in the directive. Pertinent information about the clinical investigation plan, investigation parameters and design, data collection and analysis methods etc. should be made available to the CA. It is strongly advised that Class III devices follow a well-designed post-marketing plan under the Medical Devices Vigilance. Extra care should be taken when labeling devices meant for clinical investigations. â€Å"All devices intended for clinical investigation must bear the wording exclusively for clinical investigation (Medical Devices Directive: annex 1, para 13.3(H) and the Active Implantable Medical Devices Directive: annex 1, 14.1).†2 Reporting of adverse incidents: â€Å"A serious adverse incident is one which: led to a death led to a serious deterioration in the health of the patient, user or others and includes: a life threatening illness or injury a permanent impairment to a body structure or function a condition requiring hospitalisation or increased length of existing hospitalisation a condition requiring otherwise unnecessary medical or surgical intervention and which might have led to death or serious deterioration in health had suitable action or intervention not taken place. This includes a malfunction of the device such that it has to be monitored more closely or temporarily or permanently taken out of service led to foetal distress, foetal death or a congenital abnormality or birth defect might have led to any of the above†2 All such incidents should be recorded and reported to the CA as set forth in the Regulation 16(10)(a) of the Medical Devices Regulations 2002 (SI 618) and Annex X of the Medical Devices Directive 93/42. Final written report: A report in conjunction with the Medical Devices Directive (Medical Devices Regulations 2002: Section 16(10) and Section 29(9)) should be submitted to the CA for devices undergoing investigation for a CE marking. However, Class III devices need to be highly regulated, before, after and during the clinical investigation. Owing to the high risks associated with their use, some say the risk can be quantified only as social and not scientific. â€Å"Risks, rather than being inherent within these implant devices, may be seen as socially derived, in processes of negotiation and conflict such as those in the case of hip and breast implants†¦.most recently, in the wake of the controversies surrounding breast implants and the 3M Capital hip, attention has been drawn to the uneven performance of notified bodies in the EU, which approve new products. This has led to the setting up of a new European Notified Bodies Operations Group (NEBOG) and calls by the MDA for all implants to be reclassified as high risk, Class III. A review of the operation of EU EMDD is also about to begin (MDA, 2001b). It thus appears that increased political scrutiny is being focused on this sector.†6 BIBLIOGRAPHY: THE MEDICAL DEVICES REGULATIONS: IMPLICATIONS ON HEALTHCARE AND OTHER RELATED ESTABLISHMENTS, BULLETIN No. 18, COMPETENT AUTHORITY (UK), Amended January 2006 EC MEDICAL DEVICES DIRECTIVES GUIDANCE FOR MANUFACTURERS ON CLINICAL INVESTIGATIONS TO BE CARRIED OUT IN THE UK, COMPETENT AUTHORITY (UK), Updated November 2007 THE NOTIFIED BODY, BULLETIN No. 6, COMPETENT AUTHORITY(UK), Amended January 2006 http://www.mhra.gov.uk/Howweregulate/Devices/ActiveImplantableMedicalDevicesDirective/index.htm, Last Date Accessed: April 08 2008 http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Product-specificinformationandadvice/Cochlearimplants/index.htm, Last Date Accessed: April 08 2008 Kent, Julie and Faulkner, Alex (2002) Regulating human implant technologies in Europeunderstanding the new era in medical device regulation, Health, Risk Society, 4:2, 189 209 Medical Device Development: From Prototype to Regulatory Approval, Aaron V. Kaplan, Donald S. Baim, John J. Smith, David A. Feigal, Michael Simons, David Jefferys, Thomas J. Fogarty, Richard E. Kuntz and Martin B. Leon, 2004;109;3068-3072 Circulation, DOI: 10.1161/01.CIR.0000134695.65733.64,Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX, 72514, Copyright 2004 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online, ISSN: 1524-4539.

Henry Wadsworth Longfellow Essay -- essays research papers fc

Born on February 27, 1807, in Portland, Maine, Henry Wadsworth Longfellow was raised in a Puritan family with three brothers and four sisters. While growing up he kept a good relationship with his family members. Longfellow spent many years in foreign countries to further his horizons. Longfellow’s solitary life style would not be expected from his extreme success in poetry (Williams, p.26).   Ã‚  Ã‚  Ã‚  Ã‚  Longfellow’s boyhood home was built by his grandfather, Peleg Wadsworth, in 1784-86, and was the first brick house in Portland. As a memorial to the poet, the house is still standing today. Then the house was by the seaside, where Longfellow could hear the rhythmic roar of the ocean. Probably much of his writing for his rhythms in his writing came through his listening to the wind and waves. Longfellow always visited there, especially up to the time of his father’s death in 1849 (Williams, 29).   Ã‚  Ã‚  Ã‚  Ã‚  The life of Henry Wadsworth Longfellow (1807-1882) was a mixture of triumph and tragedy, fulfillment and disappointment. His youthful ambitions were all literary, but to please his father he became a teacher. During the eight years he taught language at Bowdoin College and eighteen years at Harvard, he never quit writing. Thirteen of his books were published, including Evangeline (1847), the Poems on Slavery (1842), and The Golden Legend (1851). Longfellow also wrote poems about is family (Evangeline, preface). Longfellow’s six children...